Nuveen Asset Management, LLC Anika Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 100,076 shares of ANIK stock, worth $2.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

100,076

Previous 196,176 48.99%

Holding current value

$2.43 Million

Previous $4.98 Million 49.14%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$24.57 - $28.47 $2.36 Million - $2.74 Million	-96,100 Reduced 48.99%	100,076 $2.53 Million
Q1 2024 May 13, 2024	SELL	$21.95 - $26.42 $1.52 Million - $1.83 Million	-69,300 Reduced 26.1%	196,176 $4.98 Million
Q4 2023 Feb 14, 2024	BUY	$18.47 - $23.3 $2.37 Million - $2.99 Million	128,369 Added 93.63%	265,476 $6.02 Million
Q3 2023 Nov 14, 2023	BUY	$16.98 - $26.1 $381,285 - $586,075	22,455 Added 19.59%	137,107 $2.55 Million
Q2 2023 Aug 14, 2023	SELL	$25.16 - $28.86 $165,049 - $189,321	-6,560 Reduced 5.41%	114,652 $2.98 Million
Q1 2023 May 15, 2023	BUY	$25.91 - $32.1 $1.33 Million - $1.65 Million	51,420 Added 73.68%	121,212 $3.48 Million
Q4 2022 Feb 14, 2023	BUY	$23.85 - $31.91 $359,634 - $481,170	15,079 Added 27.56%	69,792 $2.07 Million
Q3 2022 Nov 14, 2022	SELL	$21.74 - $24.68 $18,522 - $21,027	-852 Reduced 1.53%	54,713 $1.3 Million
Q2 2022 Aug 15, 2022	SELL	$20.4 - $25.53 $70,359 - $88,052	-3,449 Reduced 5.84%	55,565 $1.24 Million
Q1 2022 May 16, 2022	BUY	$24.7 - $36.54 $13,041 - $19,293	528 Added 0.9%	59,014 $1.59 Million
Q4 2021 Feb 14, 2022	SELL	$35.83 - $45.03 $135,616 - $170,438	-3,785 Reduced 6.08%	58,486 $2.16 Million
Q3 2021 Nov 12, 2021	SELL	$38.75 - $44.47 $1.15 Million - $1.32 Million	-29,680 Reduced 32.28%	62,271 $2.47 Million
Q2 2021 Aug 16, 2021	BUY	$39.42 - $48.08 $1.07 Million - $1.31 Million	27,254 Added 42.13%	91,951 $3.98 Million
Q1 2021 May 17, 2021	SELL	$32.49 - $45.96 $29,728 - $42,053	-915 Reduced 1.39%	64,697 $2.64 Million
Q4 2020 Feb 16, 2021	SELL	$32.59 - $45.26 $60,747 - $84,364	-1,864 Reduced 2.76%	65,612 $2.97 Million
Q3 2020 Nov 16, 2020	BUY	$32.56 - $38.57 $155,018 - $183,631	4,761 Added 7.59%	67,476 $2.39 Million
Q2 2020 Aug 14, 2020	BUY	$27.83 - $37.73 $257,900 - $349,643	9,267 Added 17.34%	62,715 $2.37 Million
Q1 2020 May 14, 2020	SELL	$22.38 - $54.06 $2.18 Million - $5.26 Million	-97,303 Reduced 64.55%	53,448 $1.55 Million
Q4 2019 Feb 14, 2020	SELL	$51.85 - $73.36 $3.16 Million - $4.47 Million	-60,919 Reduced 28.78%	150,751 $7.82 Million
Q3 2019 Nov 14, 2019	BUY	$40.05 - $57.47 $6.22 Million - $8.93 Million	155,339 Added 275.76%	211,670 $11.6 Million
Q2 2019 Aug 15, 2019	BUY	$30.3 - $41.14 $1.71 Million - $2.32 Million	56,331 New	56,331 $2.29 Million

Others Institutions Holding ANIK

# of Institutions

116

Shares Held

11.8M

Call Options Held

2.7K

Put Options Held

View Full List

About Anika Therapeutics, Inc.

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $354M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

More about ANIK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Anika Therapeutics, Inc. Transaction History